<VariationArchive VariationID="1377914" VariationName="NM_000302.4(PLOD1):c.467-2del" VariationType="Deletion" Accession="VCV001377914" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2022-03-28" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1469719" VariationID="1377914">
      <GeneList>
        <Gene Symbol="PLOD1" FullName="procollagen-lysine,2-oxoglutarate 5-dioxygenase 1" GeneID="5351" HGNC_ID="HGNC:9081" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p36.22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="11934717" stop="11975537" display_start="11934717" display_stop="11975537" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="11994723" stop="12035598" display_start="11994723" display_stop="12035598" Strand="+" />
          </Location>
          <OMIM>153454</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000302.4(PLOD1):c.467-2del</Name>
      <CanonicalSPDI>NC_000001.11:11952620:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p36.22</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="11952621" stop="11952621" display_start="11952621" display_stop="11952621" variantLength="1" positionVCF="11952620" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="12012678" stop="12012678" display_start="12012678" display_stop="12012678" variantLength="1" positionVCF="12012677" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.12012678del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.12012678del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.11952621del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.11952621del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008159.1" sequenceAccession="NG_008159" sequenceVersion="1" change="g.22933del">
            <Expression>NG_008159.1:g.22933del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001316320.2" sequenceAccession="NM_001316320" sequenceVersion="2" change="c.608-2del">
            <Expression>NM_001316320.2:c.608-2del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000302.4" sequenceAccession="NM_000302" sequenceVersion="4" change="c.467-2del" MANESelect="true">
            <Expression>NM_000302.4:c.467-2del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1440249864" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00000" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000302.4(PLOD1):c.467-2del AND Ehlers-Danlos syndrome, kyphoscoliotic type 1" Accession="RCV001880899" Version="3">
        <ClassifiedConditionList TraitSetID="3964">
          <ClassifiedCondition DB="MedGen" ID="C0268342">Ehlers-Danlos syndrome, kyphoscoliotic type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-10" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-10" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10502784</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10874315</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16199547</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21699693</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3964" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1586" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">EHLERS-DANLOS SYNDROME, OCULAR-SCOLIOTIC TYPE</ElementValue>
                <XRef Type="MIM" ID="225400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EHLERS-DANLOS SYNDROME, TYPE VIA</ElementValue>
                <XRef Type="MIM" ID="225400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nevo syndrome</ElementValue>
                <XRef ID="Nevo+syndrome/5215" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ehlers-Danlos syndrome, hydroxylysine-deficient</ElementValue>
                <XRef ID="25606004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ehlers-Danlos syndrome, kyphoscoliotic type 1</ElementValue>
                <XRef ID="MONDO:0016002" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EDS6A</ElementValue>
                <XRef Type="MIM" ID="225400" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EDS6</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">EDSKSCL1</ElementValue>
                <XRef Type="MIM" ID="225400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Ehlers-Danlos Syndrome, Kyphoscoliotic Form</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="22216" />
                <XRef ID="22216" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">PLOD1-related kyphoscoliotic Ehlers-Danlos syndrome (kEDS) is an autosomal recessive generalized connective tissue disorder characterized by hypotonia, early-onset kyphoscoliosis, and generalized joint hypermobility in association with skin fragility and ocular abnormality. Intelligence is normal. Life span may be normal, but affected individuals are at risk for rupture of medium-sized arteries. Adults with severe kyphoscoliosis are at risk for complications from restrictive lung disease, recurrent pneumonia, and cardiac failure.</Attribute>
                <XRef ID="NBK1462" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000525812" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000509007" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510821" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514633" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515704" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522328" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529376" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000500398" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000561718" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301635</ID>
                <ID Source="BookShelf">NBK1462</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">2987428</ID>
              </Citation>
              <XRef ID="1900" DB="Orphanet" />
              <XRef ID="C0268342" DB="MedGen" />
              <XRef ID="MONDO:0016002" DB="MONDO" />
              <XRef Type="MIM" ID="225400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4156308" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="2942754|MedGen:C0268342" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002142792" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16199547</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10874315</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21699693</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10502784</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10502784</ID>
          </Citation>
          <Comment>This sequence change affects a splice site in intron 4 of the PLOD1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in PLOD1 are known to be pathogenic (PMID: 10874315, 21699693). This variant is present in population databases (no rsID available, gnomAD 0.0009%). Disruption of this splice site has been observed in individual(s) with Ehlers-Danlos syndrome, kyphoscoliotic form (PMID: 10502784). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 1377914). Studies have shown that disruption of this splice site alters PLOD1 gene expression (PMID: 10502784). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PLOD1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.12012678del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268342" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4156308" TraitType="Disease" MappingType="XRef" MappingValue="C0268342" MappingRef="MedGen">
        <MedGen CUI="C0268342" Name="Ehlers-Danlos syndrome, kyphoscoliotic type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

